Related Experiment Video
Updated: Feb 28, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
1Laboratory of Cancer Biology and Genomics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA.
Abstract:
Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discovery of the bacterial clustered regularly interspaced palindromic repeat (CRISPR) system and its subsequent adaptation as a tool for mammalian genome engineering has opened up new avenues for functional genomics studies. This review will focus on the utility of CRISPR in the context of cancer drug target discovery.
Insights
New technologies like CRISPR gene editing are revolutionizing cancer research. This review explores how CRISPR advances functional genomics and aids in discovering novel cancer drug targets.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Technological advancements drive translational research in oncology.
- Microarrays, next-generation sequencing, proteomics, and RNA interference (RNAi) have improved cancer mechanism understanding and drug target discovery.
- The bacterial clustered regularly interspaced palindromic repeat (CRISPR) system offers new possibilities for functional genomics.
Purpose of the Study:
- To review the utility of CRISPR technology for cancer drug target discovery.
- To highlight CRISPR's role in advancing functional genomics in cancer research.
Main Methods:
- Review of existing literature on CRISPR applications in cancer research.
- Focus on CRISPR's adaptation for mammalian genome engineering.
- Analysis of CRISPR's contribution to identifying potential cancer drug targets.
Main Results:
- CRISPR enables precise genome engineering for functional genomics studies.
- CRISPR facilitates the identification and validation of novel cancer drug targets.
- The technology accelerates the understanding of cancer biology.
Conclusions:
- CRISPR technology is a powerful tool for cancer drug target discovery.
- Its application in functional genomics is transforming cancer research avenues.
- Further exploration of CRISPR's potential in oncology is warranted.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
What is Genetic Engineering?
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

